Combined Stimulation of the Substantia Nigra and the Subthalamic Nucleus for the Treatment of Refractory Gait Disturbances in Parkinson’s Disease: A Preliminary Study by Marta Villadóniga, Lidia Cabañes-Martínez, Laura López-Viñas, Samira Fanjul, Marta del Álamo, Ignacio Regidor

Get full text

Defining the specificity of cotranslationally acting chaperones by systematic analysis of mRNAs associated with ribosome-nascent chain complexes. by Marta del Alamo, Daniel J Hogan, Sebastian Pechmann, Veronique Albanese, Patrick O Brown, Judith Frydman

Get full text

An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells. by Jon Gil-Ranedo, Marina Mendiburu-Eliçabe, Mercedes García-Villanueva, Diego Medina, Marta del Álamo, Marta Izquierdo

Get full text

Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases by Marta del Álamo, Christoph Bührer, Dirk Fisher, Matthias Griese, Paul Lingor, Giovanni Palladini, Nicolas Sireau, Virginie Hivert, Luca Sangiorgi, Florence Guillot, Juliane Halftermeyer, Lenka Soucková, Kristýna Nosková, Regina Demlová

Get full text

Neuroimaging signatures predicting motor improvement to focused ultrasound subthalamotomy in Parkinson’s disease by Sue-Jin Lin, Rafael Rodriguez-Rojas, Tobias R. Baumeister, Christophe Lenglos, Jose A. Pineda-Pardo, Jorge U. Máñez-Miró, Marta del Alamo, Raul Martinez-Fernandez, Jose A. Obeso, Yasser Iturria-Medina

Get full text

Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia by Carmen Gasca-Salas, Beatriz Fernández-Rodríguez, José A. Pineda-Pardo, Rafael Rodríguez-Rojas, Ignacio Obeso, Frida Hernández-Fernández, Marta del Álamo, David Mata, Pasqualina Guida, Carlos Ordás-Bandera, J. Ignacio Montero-Roblas, Raúl Martínez-Fernández, Guglielmo Foffani, Itay Rachmilevitch, José A. Obeso

Get full text

Protocol for a multicentre, parallel, randomised, controlled trial on the effect of sweeteners and sweetness enhancers on health, obesity and safety in overweight adults and childr... by Ellen E Blaak, Marta del Álamo, Yannis Manios, Graham Finlayson, Edith J M Feskens, Anne Raben, Jason C G Halford, Joanne A Harrold, Louise Kjølbæk, J. Alfredo Martínez, Sabina S H Andersen, Kyriakos Reppas, Santiago Navas-Carretero, Tanja C Adam, Charo E Hodgkins, Tony Lam, Hariklia Moshoyiannis

Get full text

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial by Marius Trøseid, José R. Arribas, Lambert Assoumou, Aleksander Rygh Holten, Julien Poissy, Vida Terzić, Fulvia Mazzaferri, Jesús Rodríguez Baño, Joe Eustace, Maya Hites, Michael Joannidis, José-Artur Paiva, Jean Reuter, Isabel Püntmann, Thale D. J. H. Patrick-Brown, Elin Westerheim, Katerina Nezvalova-Henriksen, Lydie Beniguel, Tuva Børresdatter Dahl, Maude Bouscambert, Monika Halanova, Zoltán Péterfi, Sotirios Tsiodras, Michael Rezek, Matthias Briel, Serhat Ünal, Martin Schlegel, Florence Ader, Karine Lacombe, Cecilie Delphin Amdal, Serge Rodrigues, Kristian Tonby, Alexandre Gaudet, Lars Heggelund, Joy Mootien, Asgeir Johannessen, Jannicke Horjen Møller, Beatriz Diaz Pollan, Anders Aune Tveita, Anders Benjamin Kildal, Jean-Christophe Richard, Olav Dalgard, Victoria Charlotte Simensen, Aliou Baldé, Lucie de Gastines, Marta del Álamo, Burç Aydin, Fridtjof Lund-Johansen, Mary-Anne Trabaud, Alpha Diallo, Bente Halvorsen, John-Arne Røttingen, Evelina Tacconelli, Yazdan Yazdanpanah, Inge C. Olsen, Dominique Costagliola, EU SolidAct study group

Get full text